Abate Kristin (CIK 2045943) reported 13 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-09-02). Recent activity: Sell KPTI (19 shares), Buy KPTI (121 shares), Sell KPTI (53 shares), Sell KPTI (559 shares), Buy KPTI (92 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-02 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Sell | 19 | $38 |
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Buy | 121 | $0 |
| 2026-05-15 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Sell | 53 | $504 |
| 2026-03-03 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Sell | 559 | $5,260 |
| 2026-01-29 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Buy | 92 | $0 |
| 2026-01-29 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Sell | 50 | $352 |
| 2026-01-22 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Sell | 265 | $1,579 |
| 2025-10-16 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Buy | 12,799 | $0 |
| 2025-10-03 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Sell | 362 | $2,281 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Buy | 46 | $0 |
| 2025-09-16 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Sell | 23 | $148 |
| 2025-09-04 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Sell | 12 | $81 |
| 2025-07-23 | Karyopharm Therapeutics Inc. (KPTI) | Chief Accounting Officer | Sell | 238 | $952 |
来源：SEC Form 4 申报文件 · 截至 2026-09-02